Literature DB >> 1906154

Modulation of platelet-derived growth factor A- and B-chain/c-sis mRNA by tumor necrosis factor and other agents in adenocarcinoma cells.

H Kalthoff1, C Roeder, I Humburg, H G Thiele, H Greten, W Schmiegel.   

Abstract

Human Platelet Derived Growth Factors (PDGF) are potent mitogens for mesenchymal cells and encoded by two related genes, the A- (or 1-) and B- (or 2-) chain. The latter is known as the human homolog (c-sis) of the v-sis oncogene. We investigated the expression and cytokine-mediated regulation of PDGF A- and B-chain mRNA in endoderm-derived cells, i.e. cultured human pancreatic adenocarcinoma cells. Northern blot analysis revealed that out of 14 cells lines 11 were positive for the A-chain and 10 for the B-chain. Tumor Necrosis Factor (TNF) -alpha and -beta, but not Interferon (IFN) -gamma, drastically upregulate the mRNA levels for PDGF B-chain and for the A-chain in a dose-dependent manner in nearly every pancreatic tumor cell line investigated (n = 6). With respect to the signal pathway stimulated by TNF, no evidence emerged for an activation of protein kinase A. The inhibition of protein kinase C by staurosporine (in the absence or presence of TNF) as well as its stimulation by PMA resulted in an increased mRNA level for the B-chain, indicating a functional role of PKC in this system. Furthermore, time course experiments and Cycloheximide treatment showed that the A- and B-chain mRNA are regulated by different mechanisms in transformed epithelial cells. Irrespective of these differences, the sum of their biological functions may contribute to the phenomenon of desmoplasia in pancreatic tumors by epithelial/mesenchymal interactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906154

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  The role of cytokines in pancreatic cancer.

Authors:  J Schmielau; H Kalthoff; C Roeder; W Schmiegel
Journal:  Int J Pancreatol       Date:  1996-06

2.  Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis.

Authors:  M Ebert; H U Kasper; S Hernberg; H Friess; M W Büchler; A Roessner; M Korc; P Malfertheiner
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

3.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

4.  Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.

Authors:  Hao Feng; Bao-Chi Ou; Jing-Kun Zhao; Shuai Yin; Ai-Guo Lu; Eva Oechsle; Wolfgang E Thasler
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-11       Impact factor: 4.553

5.  Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer.

Authors:  W Schmiegel; J Schmielau; D Henne-Bruns; H Juhl; C Roeder; P Buggisch; A Onur; B Kremer; H Kalthoff; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

6.  Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha.

Authors:  H Kalthoff; C Roeder; J Gieseking; I Humburg; W Schmiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

7.  PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types.

Authors:  A Mishra; A K Ormerod; M L Cibull; B T Spear; S D Kraner; D M Kaetzel
Journal:  Cancer Gene Ther       Date:  2008-11-07       Impact factor: 5.987

8.  A Multi-institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic Cancer.

Authors:  Rebecca A Moss; Dirk Moore; Mary F Mulcahy; Kenneth Nahum; Biren Saraiya; Simantini Eddy; Martin Kleber; Elizabeth A Poplin
Journal:  Gastrointest Cancer Res       Date:  2012-05

9.  Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells.

Authors:  W Schmiegel; C Roeder; J Schmielau; U Rodeck; H Kalthoff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

10.  Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages.

Authors:  X Tan; W Hsueh; F Gonzalez-Crussi
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.